SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-041943
Filing Date
2024-04-01
Accepted
2024-04-01 17:09:47
Documents
13
Period of Report
2024-04-01
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2410371d2_8k.htm   iXBRL 8-K 32442
  Complete submission text file 0001104659-24-041943.txt   205946

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20240401.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20240401_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20240401_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2410371d2_8k_htm.xml XML 3492
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 24810780
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)